Variant report

Variant	nsv946515
Chromosome Location	chr1:175890137-175903482
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:112)
CpG islands
(count:61)
Chromatin interactive
region (count:3)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:112 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr1:175891245-175891850	H1-hESC	embryonic stem cell:	n/a	n/a
2	CBX3	chr1:175896992-175897459	HCT-116	colon:	n/a	n/a
3	CHD2	chr1:175891387-175891830	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr1:175903040-175903190	Caco-2	colon:	n/a	n/a
5	CTCF	chr1:175903020-175903170	Caco-2	colon:	n/a	n/a
6	CTCF	chr1:175903000-175903150	HPAF	blood vessel:	n/a	n/a
7	CTCF	chr1:175903020-175903170	AG10803	skin:	n/a	n/a
8	CTCF	chr1:175903080-175903230	NHDF-neo	bronchial:	n/a	n/a
9	CTCF	chr1:175903020-175903170	AG09319	gingival:	n/a	n/a
10	CTCF	chr1:175902980-175903130	BJ	skin:	n/a	n/a
11	CTCF	chr1:175903085-175903116	MCF-7	breast:	n/a	n/a
12	CTCF	chr1:175902980-175903130	HVMF	connective:	n/a	n/a
13	CTCF	chr1:175903000-175903150	WERI-Rb-1	eye:	n/a	n/a
14	CTCF	chr1:175902887-175903206	H1-hESC	embryonic stem cell:	n/a	n/a
15	CTCF	chr1:175903060-175903210	SAEC	small airway:	n/a	n/a
16	CTCF	chr1:175902940-175903090	A549	lung:	n/a	n/a
17	CTCF	chr1:175903043-175903170	ProgFib	skin:	n/a	n/a
18	CTCF	chr1:175903058-175903117	Hela-S3	cervix:	n/a	n/a
19	CTCF	chr1:175903000-175903150	BJ	skin:	n/a	n/a
20	CTCF	chr1:175902940-175903090	NHDF-neo	bronchial:	n/a	n/a
21	CTCF	chr1:175903087-175903125	HepG2	liver:	n/a	n/a
22	CTCF	chr1:175902960-175903110	HVMF	connective:	n/a	n/a
23	CTCF	chr1:175902969-175903203	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTCF	chr1:175903081-175903123	A549	lung:	n/a	n/a
25	CTCF	chr1:175902940-175903090	AG04450	lung:	n/a	n/a
26	CTCF	chr1:175895478-175895544	GM20000	blood:	n/a	n/a
27	CTCF	chr1:175903040-175903190	HFF	foreskin:	n/a	n/a
28	E2F6	chr1:175891299-175891788	H1-hESC	embryonic stem cell:	n/a	n/a
29	E2F6	chr1:175891395-175891691	H1-hESC	embryonic stem cell:	n/a	n/a
30	EP300	chr1:175891342-175891851	H1-hESC	embryonic stem cell:	n/a	n/a
31	EP300	chr1:175896998-175897198	K562	blood:	n/a	n/a
32	GABPA	chr1:175902999-175903218	H1-hESC	embryonic stem cell:	n/a	n/a
33	GATA2	chr1:175889724-175890151	SH-SY5Y	brain:	n/a	chr1:175889977-175889994 chr1:175889976-175889983 chr1:175889871-175889878 chr1:175889871-175889878 chr1:175889871-175889881 chr1:175889871-175889878 chr1:175889869-175889879 chr1:175889976-175889985
34	GATA3	chr1:175893216-175893326	SH-SY5Y	brain:	n/a	n/a
35	GTF2F1	chr1:175891695-175891822	H1-hESC	embryonic stem cell:	n/a	n/a
36	GTF2F1	chr1:175891459-175891461	H1-hESC	embryonic stem cell:	n/a	n/a
37	HEY1	chr1:175891042-175891228	K562	blood:	n/a	n/a
38	HEY1	chr1:175891022-175891266	HepG2	liver:	n/a	n/a
39	HEY1	chr1:175891058-175891230	HepG2	liver:	n/a	n/a
40	HEY1	chr1:175891028-175891311	K562	blood:	n/a	n/a
41	JUND	chr1:175902995-175903224	H1-hESC	embryonic stem cell:	n/a	n/a
42	JUND	chr1:175891407-175891944	H1-hESC	embryonic stem cell:	n/a	n/a
43	KAP1	chr1:175897021-175897568	HEK293	kidney:	n/a	n/a
44	KAP1	chr1:175896936-175897595	K562	blood:	n/a	n/a
45	KAP1	chr1:175897081-175897543	U2OS	brain:	n/a	n/a
46	MAX	chr1:175891300-175891751	H1-hESC	embryonic stem cell:	n/a	n/a
47	MAX	chr1:175891262-175891750	H1-hESC	embryonic stem cell:	n/a	n/a
48	MAX	chr1:175891298-175891814	H1-hESC	embryonic stem cell:	n/a	n/a
49	MYC	chr1:175891383-175891583	H1-hESC	embryonic stem cell:	n/a	n/a
50	NANOG	chr1:175891397-175891793	H1-hESC	embryonic stem cell:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:175891165-175891215	AG04449	skin:	fetal
2	chr1:175891165-175891215	HCM	heart:	n/a
3	chr1:175891165-175891215	GM12892	blood:	n/a
4	chr1:175891165-175891215	U87	brain:	n/a
5	chr1:175891165-175891215	PFSK-1	brain:	n/a
6	chr1:175891165-175891215	Jurkat	blood:	n/a
7	chr1:175891165-175891215	T-47D	breast:	n/a
8	chr1:175891165-175891215	Hepatocyte	liver:	n/a
9	chr1:175891165-175891215	PrEC	prostate:	n/a
10	chr1:175891165-175891215	GM12891	blood:	n/a
11	chr1:175891165-175891215	K562	blood:	n/a
12	chr1:175891165-175891215	HMEC	breast:	n/a
13	chr1:175891165-175891215	HRPEpiC	eye:	n/a
14	chr1:175891165-175891215	MCF-7	breast:	n/a
15	chr1:175891165-175891215	ovcar-3	ovarian:	n/a
16	chr1:175891165-175891215	HNPCEpiC	eye:	n/a
17	chr1:175891165-175891215	GM06990	blood:	n/a
18	chr1:175891165-175891215	GM19239	blood:	n/a
19	chr1:175891165-175891215	AG10803	skin:	n/a
20	chr1:175891165-175891215	LNCaP	prostate:	n/a
21	chr1:175891165-175891215	Caco-2	colon:	n/a
22	chr1:175891165-175891215	HL-60	blood:	n/a
23	chr1:175891165-175891215	AG09319	gingival:	n/a
24	chr1:175891165-175891215	H1-hESC	embryonic stem cell:	embryo
25	chr1:175891165-175891215	HCT-116	colon:	n/a
26	chr1:175891165-175891215	CMK	blood:	n/a
27	chr1:175891165-175891215	HEK293	kidney:	embryo
28	chr1:175891165-175891215	SKMC	muscle:	n/a
29	chr1:175891165-175891215	HRE	kidney:	n/a
30	chr1:175891165-175891215	ProgFib	skin:	n/a
31	chr1:175891165-175891215	A549	lung:	n/a
32	chr1:175891165-175891215	MCF10A-Er-Src	breast:	n/a
33	chr1:175891165-175891215	NH-A	brain:	n/a
34	chr1:175891165-175891215	AG04450	lung:	fetal
35	chr1:175891165-175891215	SAEC	small airway:	n/a
36	chr1:175891165-175891215	HEEpiC	esophagus:	n/a
37	chr1:175891165-175891215	AG09309	skin:	n/a
38	chr1:175891165-175891215	HIPEpiC	eye:	n/a
39	chr1:175891165-175891215	PANC-1	pancreas:	n/a
40	chr1:175891165-175891215	HPAEpiC	pulmonary alveolar:	n/a
41	chr1:175891165-175891215	SK-N-SH_RA	brain:	n/a
42	chr1:175891165-175891215	HepG2	liver:	n/a
43	chr1:175891165-175891215	SK-N-SH	brain:	n/a
44	chr1:175891165-175891215	RPTEC	kidney:	n/a
45	chr1:175891165-175891215	SK-N-MC	brain:	n/a
46	chr1:175891165-175891215	NHDF-neo	bronchial:	n/a
47	chr1:175891165-175891215	GM12878	blood:	n/a
48	chr1:175891165-175891215	IMR90	lung:	fetal
49	chr1:175891165-175891215	Hela-S3	cervix:	n/a
50	chr1:175891165-175891215	HCF	heart:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr1:175889913..175891691-chr1:175893710..175896075,2	K562	blood:
2	chr1:175896580..175899255-chr1:175903539..175906288,2	K562	blood:
3	chr1:175881029..175882738-chr1:175891650..175894034,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RFWD2-4	chr1:175902493-175902755	NONHSAT007762
2	lnc-RFWD2-3	chr1:175891088-175891315	NONHSAT007764
3	lnc-PAPPA2-7	chr1:175896225-175899638	NONHSAT007766

No data

Variant related genes	Relation type
ENSG00000230777	TF binding region
ENSG00000227740	TF binding region
ENSG00000230777	CpG island
ENSG00000227740	CpG island
ENSG00000230777	chromatin interactions

Extended variants
information (count: 514 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:514 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs567079535	chr1:175890157-175890158	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs147773325	chr1:175890162-175890163	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs141191806	chr1:175890187-175890188	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs531086589	chr1:175890280-175890281	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs112764961	chr1:175890291-175890292	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs570476432	chr1:175890293-175890294	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs376753170	chr1:175890297-175890298	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs376744171	chr1:175890307-175890308	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs2030557	chr1:175890377-175890378	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs565743046	chr1:175890406-175890407	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs10913102	chr1:175890426-175890427	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs376730480	chr1:175890432-175890433	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs200542021	chr1:175890437-175890438	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs567087965	chr1:175890438-175890439	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs146962496	chr1:175890442-175890443	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs537330041	chr1:175890465-175890466	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs557013876	chr1:175890497-175890498	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs115841960	chr1:175890524-175890525	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs572637708	chr1:175890531-175890532	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs368569924	chr1:175890532-175890533	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs545584022	chr1:175890554-175890555	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs188677354	chr1:175890556-175890557	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs35315142	chr1:175890557-175890558	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs6657567	chr1:175890558-175890559	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs542437101	chr1:175890586-175890587	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs73046285	chr1:175890619-175890620	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs6681342	chr1:175890630-175890631	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs368254845	chr1:175890643-175890644	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
29	rs370043294	chr1:175890733-175890734	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs193198208	chr1:175890745-175890746	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs141726206	chr1:175890755-175890756	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs35306505	chr1:175890776-175890777	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs546665256	chr1:175890844-175890845	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs4652139	chr1:175890851-175890852	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs116991608	chr1:175890957-175890958	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs548401956	chr1:175890970-175890971	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs541221971	chr1:175890973-175890974	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs568228819	chr1:175891009-175891010	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs574848630	chr1:175891026-175891027	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs77637705	chr1:175891069-175891070	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs78438358	chr1:175891070-175891071	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs79272212	chr1:175891071-175891072	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs35237297	chr1:175891086-175891087	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs557247053	chr1:175891101-175891102	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
45	rs540087483	chr1:175891105-175891106	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
46	rs112620911	chr1:175891111-175891112	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
47	rs202144483	chr1:175891143-175891144	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs539459831	chr1:175891145-175891146	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs150151239	chr1:175891153-175891154	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs112043461	chr1:175891166-175891167	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	16750200	CNVD
Liposarcoma	21253554	CNVD
Burkitt''s lymphoma	18698080	CNVD
Melanoma	18172304	CNVD
Cancer	21183584	CNVD
Multiple myeloma	16461302	CNVD
Rett syndrome	21593744	CNVD
Cancer	20164919	CNVD
Medulloblastoma	21979893	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21829676	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Bladder cancer	19088036	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	21858162	CNVD
Retinoblastoma	19183342	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chordoma	18071362	CNVD
Hepatocellular carcinoma	18803288	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Urothelial carcinoma	21177765	CNVD
Burkitt''s lymphoma	19759907	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Trisomy 5 syndrome	21098271	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Developmental delay	21147756	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Breast cancer	21509527	CNVD
Glioblastoma multiforme	17369134	CNVD
Cancer	17440070	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	21611746	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:227 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:175863200-175906400	Weak transcription	Muscle Satellite Cultured Cells	--
2	chr1:175874400-175945600	Weak transcription	A549	lung
3	chr1:175877400-175894600	Weak transcription	HSMM	muscle
4	chr1:175877800-175902400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
5	chr1:175879800-175896000	Weak transcription	Fetal Stomach	stomach
6	chr1:175880000-175897200	Weak transcription	Fetal Muscle Trunk	muscle
7	chr1:175880000-175897400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
8	chr1:175880000-175937800	Weak transcription	HSMMtube	muscle
9	chr1:175880400-175891800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr1:175880400-175904400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
11	chr1:175880600-175896200	Weak transcription	Placenta	Placenta
12	chr1:175880600-175896400	Weak transcription	Cortex derived primary cultured neurospheres	brain
13	chr1:175881000-175897200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr1:175881000-175905200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr1:175881000-175924200	Weak transcription	Brain Angular Gyrus	brain
16	chr1:175881200-175894800	Weak transcription	Primary T cells from cord blood	blood
17	chr1:175881400-175893400	Weak transcription	GM12878-XiMat	blood
18	chr1:175881400-175894800	Weak transcription	Fetal Muscle Leg	muscle
19	chr1:175881400-175896600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
20	chr1:175881400-175897400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
21	chr1:175882000-175895000	Weak transcription	Duodenum Smooth Muscle	Duodenum
22	chr1:175882600-175894600	Weak transcription	Fetal Brain Female	brain
23	chr1:175882600-175895600	Weak transcription	Lung	lung
24	chr1:175882600-175902200	Weak transcription	Aorta	Aorta
25	chr1:175882600-175910200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr1:175883200-175895000	Weak transcription	Adipose Nuclei	Adipose
27	chr1:175883200-175908200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr1:175884200-175897400	Weak transcription	Pancreas	Pancrea
29	chr1:175885800-175896400	Weak transcription	Stomach Smooth Muscle	stomach
30	chr1:175885800-175897200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
31	chr1:175885800-175897400	Weak transcription	Left Ventricle	heart
32	chr1:175886000-175895000	Weak transcription	Ovary	ovary
33	chr1:175886200-175896200	Weak transcription	Primary T helper cells PMA-I stimulated	--
34	chr1:175886400-175929400	Weak transcription	Brain Inferior Temporal Lobe	brain
35	chr1:175886800-175890800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr1:175887600-175895000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
37	chr1:175887800-175896400	Weak transcription	Brain Hippocampus Middle	brain
38	chr1:175887800-175929800	Weak transcription	Skeletal Muscle Female	skeletal muscle
39	chr1:175888000-175890600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
40	chr1:175888200-175890600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
41	chr1:175889200-175890800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
42	chr1:175889200-175937800	Weak transcription	Osteobl	bone
43	chr1:175889400-175891200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
44	chr1:175889400-175896800	Weak transcription	Fetal Lung	lung
45	chr1:175889600-175892600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
46	chr1:175889800-175890200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr1:175889800-175890600	Weak transcription	Primary monocytes fromperipheralblood	blood
48	chr1:175890000-175890400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
49	chr1:175890000-175890400	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
50	chr1:175890000-175890600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links